Disclosure
RAI summary · Not investment advice
Remedi's extraordinary general meeting on October 27, 2026 approved the re-appointment of inside director Cho Bong-ho.
Commentary
AI commentary · Not investment advice
What happened
Remedi held an extraordinary general meeting on October 27, 2026, and approved Agenda Item 1, the election of Cho Bong-ho as an inside director. This was a re-election rather than a new appointment, and Mr. Cho currently serves as Remedi's chief executive officer.
In the company's terms
Relative to the company, there were 2 earlier filings of the same type within the past year, dated October 12, 2026 and September 15, 2026. This filing was received on October 27, 2026, the same day as the meeting.
Show Korean comments
Comments
No comments yet
Comments from shareholders will appear here.
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist